| 000 | 01542 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515162449.0 | ||
| 264 | 0 | _c20091013 | |
| 008 | 200910s 0 0 eng d | ||
| 022 | _a1099-1069 | ||
| 024 | 7 |
_a10.1002/hon.891 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHitz, F | |
| 245 | 0 | 0 |
_aA multicentre phase II trial of gemcitabine for the treatment of patients with newly diagnosed, relapsed or chemotherapy resistant mantle cell lymphoma: SAKK 36/03. _h[electronic resource] |
| 260 |
_bHematological oncology _cSep 2009 |
||
| 300 |
_a154-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xadverse effects |
| 650 | 0 | 4 |
_aDeoxycytidine _xadverse effects |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, Mantle-Cell _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aGemcitabine |
| 700 | 1 | _aMartinelli, G | |
| 700 | 1 | _aZucca, E | |
| 700 | 1 | _avon Moos, R | |
| 700 | 1 | _aMingrone, W | |
| 700 | 1 | _aSimcock, M | |
| 700 | 1 | _aPeterson, J | |
| 700 | 1 | _aCogliatti, S B | |
| 700 | 1 | _aBertoni, F | |
| 700 | 1 | _aZimmermann, D R | |
| 700 | 1 | _aGhielmini, M | |
| 773 | 0 |
_tHematological oncology _gvol. 27 _gno. 3 _gp. 154-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/hon.891 _zAvailable from publisher's website |
| 999 |
_c18714473 _d18714473 |
||